← FDA Drug Approvals (Drugs@FDA)
SYMPAZAN
NDA · New Drug Application · Sponsor: ASSERTIO SPECLTY · Approved 2018-11-01
Drug application
- FDA Application #
NDA210833- Application type
- New Drug Application
- Brand name
- SYMPAZAN
- Generic name
- CLOBAZAM
- Active ingredients
- CLOBAZAM
- Dosage form
- FILM
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ASSERTIO SPECLTY
- Manufacturer
- Aquestive Therapeutics
- First approval
- 2018-11-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown